Literature DB >> 8673642

The effects of preclinical dementia on estimates of normal cognitive functioning in aging.

M Sliwinski1, R B Lipton, H Buschke, W Stewart.   

Abstract

Individuals with preclinical dementia have begun to decline cognitively, but still perform within normal limits on cognitive testing. As a group, subjects with preclinical dementia have lower scores on neuropsychological tests than their dementia-free counterparts. This study examines the effects of preclinical dementia on estimates of normal cognitive function in the aged using data from a longitudinal study. Individuals with preclinical dementia at baseline were retrospectively identified based on subsequent development of dementia. Age-adjusted norms were computed using baseline data for the Selective Reminding Test and the WAIS verbal and performance scores, both including (conventional norms) and then excluding (robust norms) preclinical cases. The results indicate that by failing to exclude preclinical dementia, conventional normative studies underestimate the mean, overestimate the variance, and overestimate the effect of age on cognitive measures. Methods are discussed for selecting robust elderly samples that are relatively free of contamination by preclinical dementia.

Entities:  

Mesh:

Year:  1996        PMID: 8673642     DOI: 10.1093/geronb/51b.4.p217

Source DB:  PubMed          Journal:  J Gerontol B Psychol Sci Soc Sci        ISSN: 1079-5014            Impact factor:   4.077


  56 in total

Review 1.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

2.  Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.

Authors:  John C Morris
Journal:  Arch Neurol       Date:  2012-06

3.  Predicting conversion to dementia of the Alzheimer's type in a healthy control sample: the power of errors in Stroop color naming.

Authors:  David A Balota; Chi-Shing Tse; Keith A Hutchison; Daniel H Spieler; Janet M Duchek; John C Morris
Journal:  Psychol Aging       Date:  2010-03

4.  Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2014-08-26       Impact factor: 2.892

5.  Older adults in the SeniorWISE study at risk for mild cognitive impairment.

Authors:  Graham J McDougall; Heather Becker; Kristopher L Arheart
Journal:  Arch Psychiatr Nurs       Date:  2006-06       Impact factor: 2.218

Review 6.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

7.  Text comprehension products and processes in young, young-old, and old-old adults.

Authors:  Debra McGinnis
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-03-12       Impact factor: 4.077

8.  Abnormal P600 word repetition effect in elderly persons with preclinical Alzheimer's disease.

Authors:  John M Olichney; Jamie Pak; David P Salmon; Jin-Chen Yang; Tim Gahagan; Ralph Nowacki; Lawrence Hansen; Douglas Galasko; Marta Kutas; Vicente J Iragui-Madoz
Journal:  Cogn Neurosci       Date:  2013-10-04       Impact factor: 3.065

Review 9.  Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia.

Authors:  Howard Chertkow; Fadi Massoud; Ziad Nasreddine; Sylvie Belleville; Yves Joanette; Christian Bocti; Valérie Drolet; John Kirk; Morris Freedman; Howard Bergman
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

10.  Mild Cognitive Impairment in Late Middle Age in the Wisconsin Registry for Alzheimer's Prevention Study: Prevalence and Characteristics Using Robust and Standard Neuropsychological Normative Data.

Authors:  Lindsay R Clark; Rebecca L Koscik; Christopher R Nicholas; Ozioma C Okonkwo; Corinne D Engelman; Lisa C Bratzke; Kirk J Hogan; Kimberly D Mueller; Barbara B Bendlin; Cynthia M Carlsson; Sanjay Asthana; Mark A Sager; Bruce P Hermann; Sterling C Johnson
Journal:  Arch Clin Neuropsychol       Date:  2016-11-22       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.